Physician profile
Ethan Lopez
NPI 1649703513
$1,621.74
in general payments reported to CMS, 2019-2025
9 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $388 · 2021: $93.98 · 2022: $19.66 · 2023: $473 · 2024: $253 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $633.63 | 2020-2025 | Mounjaro, Kisunla, Jardiance |
| Amgen INC. | $353.04 | 2021-2025 | Otezla, Evenity, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $124.98 | 2025 | |
| Amarin Pharma, INC. | $116.44 | 2020 | |
| Abbott Laboratories | $107.66 | 2023 | Proclaim |
| Janssen Pharmaceuticals, INC | $99.99 | 2023 | Xarelto |
| Merck Sharp & Dohme LLC | $89.29 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $77.39 | 2020 | |
| Glaxosmithkline, LLC. | $19.32 | 2025 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.